Catalyst Biosciences, Inc. (CBIO) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$11.81
Day's range
$12.3

Crescent Biopharma Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/17/2026 4.13 M $49.02 M   192.19% 4.55%
BVF INC/IL 02/17/2026 2.75 M $32.60 M   98.06% 3.03%
FAIRMOUNT FUNDS MANAGEMENT LLC 02/17/2026 2.75 M $32.59 M   97.99% 3.02%
VR ADVISER, LLC 02/17/2026 2.13 M $25.30 M   53.73% 2.35%
FCPM III SERVICES B.V. 02/17/2026 1.68 M $19.90 M   100.00% 1.85%
VESTAL POINT CAPITAL, LP 02/17/2026 1.50 M $17.79 M   100.00% 1.65%
OPALEYE MANAGEMENT INC. 04/13/2026 1.18 M $13.97 M   100.00% 1.30%
TANG CAPITAL MANAGEMENT LLC 02/17/2026 872.40 K $10.35 M   28.33% 0.96%
ADAR1 CAPITAL MANAGEMENT, LLC 02/18/2026 606.00 K $7.19 M   100.00% 0.67%
LOGOS GLOBAL MANAGEMENT LP 02/17/2026 600.00 K $7.12 M   0.00% 0.66%
VANGUARD GROUP INC 01/29/2026 557.51 K $6.61 M   -15.26% 0.61%
PERCEPTIVE ADVISORS LLC 02/17/2026 453.69 K $5.38 M   0.00% 0.50%
DEEP TRACK CAPITAL, LP 02/13/2026 453.69 K $5.38 M   0.00% 0.50%
BOXER CAPITAL MANAGEMENT, LLC 02/17/2026 453.69 K $5.38 M   0.00% 0.50%
RTW INVESTMENTS, LP 02/17/2026 372.86 K $4.42 M   100.00% 0.41%
02/13/2026 372.86 K $4.42 M   100.00% 0.41%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 338.13 K $4.01 M   -11.85% 0.37%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/17/2026 302.46 K $3.59 M   0.00% 0.33%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 300.00 K $3.56 M   100.00% 0.33%
HEIGHTS CAPITAL MANAGEMENT, INC 02/17/2026 264.00 K $3.13 M   100.00% 0.29%
ALYESKA INVESTMENT GROUP, L.P. 02/13/2026 264.00 K $3.11 M   100.00% 0.29%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 143.41 K $1.63 M   710.33% 0.16%
TWO SIGMA INVESTMENTS, LP 02/17/2026 125.22 K $1.49 M   342.21% 0.14%
BALYASNY ASSET MANAGEMENT L.P. 02/17/2026 111.72 K $1.32 M   100.00% 0.12%
BLACKROCK, INC. 02/12/2026 109.23 K $1.30 M   0.11% 0.12%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 91.08 K $1.08 M   31.74% 0.10%
STONEPINE CAPITAL MANAGEMENT, LLC 02/13/2026 87.68 K $1.04 M   100.00% 0.10%
BLACKSTONE INC. 02/17/2026 75.61 K $896.78 K   0.00% 0.08%
WOODLINE PARTNERS LP 02/17/2026 74.00 K $877.64 K   100.00% 0.08%
BURKEHILL GLOBAL MANAGEMENT, LP 02/17/2026 74.00 K $844.34 K   100.00% 0.08%
JEFFERIES FINANCIAL GROUP INC. 02/09/2026 64.24 K $761.93 K   -37.45% 0.07%
MILLENNIUM MANAGEMENT LLC 02/17/2026 61.88 K $733.92 K   100.00% 0.07%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 57.05 K $676.59 K   100.00% 0.06%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 46.70 K $553.86 K   73.61% 0.05%
TWO SIGMA ADVISERS, LP 02/17/2026 32.50 K $385.45 K   100.00% 0.04%
MORGAN STANLEY 02/13/2026 27.52 K $326.40 K   18,880.00% 0.03%
STATE STREET CORP 02/13/2026 26.22 K $310.93 K   40.82% 0.03%
GOLDMAN SACHS GROUP INC 03/25/2026 25.25 K $299.41 K   -31.72% 0.03%
MOORE CAPITAL MANAGEMENT, LP 02/17/2026 25.00 K $296.50 K   100.00% 0.03%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/13/2026 24.90 K $288.95 K   -0.08% 0.03%
JANE STREET GROUP, LLC 02/12/2026 22.97 K $272.37 K   100.00% 0.03%
MARSHALL WACE, LLP 02/13/2026 21.83 K $258.86 K   -50.05% 0.02%
NORTHERN TRUST CORP 02/17/2026 17.23 K $204.34 K   2.46% 0.02%
HRT FINANCIAL LP 02/12/2026 13.08 K $155.00 K   100.00% 0.01%
JPMORGAN CHASE & CO 02/11/2026 23.34 K $276.80 K   137,188.24% 0.01%
OMERS ADMINISTRATION CORP 02/13/2026 11.60 K $137.58 K   100.00% 0.01%
UBS GROUP AG 01/29/2026 7.13 K $84.50 K   -43.72% 0.01%
BANK OF AMERICA CORP /DE/ 02/17/2026 5.57 K $66.10 K   44.27% 0.01%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 3.59 K $42.52 K   89,525.00% 0.00%
CITIGROUP INC 02/13/2026 623 $7.39 K   -21.93% 0.00%

Crescent Biopharma Inc. institutional Ownership - FAQ's

During the previous two years, 77 institutional investors and hedge funds held shares of Crescent Biopharma Inc.. The most heavily invested institutionals were:

JENNISON ASSOCIATES LLC: 152,974

UBS Group AG: 82,706

VANGUARD FIDUCIARY TRUST CO: 49,423

CITIGROUP INC: 20,169

BNP PARIBAS ARBITRAGE, SNC: 15,694

Cannon Global Investment Management, LLC: 10,200

26.13% of Crescent Biopharma Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 23.91 M shares in the last 24 months. This purchase volume represents approximately $287.43 M in transactions.